Scientific Sessions 2025  /  Adding Years to Life and Life to Years  /  Evidence and Innovation in Lifetime Management of Aortic Valve Disease
Logo

American Heart Association

  36
  0

Final ID:

Evidence and Innovation in Lifetime Management of Aortic Valve Disease

  • George, Isaac  ( Columbia University Medical Center , New York , New York , United States )
    • Author Disclosures:
    Isaac George: DO have relevant financial relationships ; Consultant:edwards:Active (exists now) ; Individual Stocks/Stock Options:vdyne:Active (exists now) ; Consultant:encompass:Active (exists now) ; Consultant:xeltis:Active (exists now) ; Individual Stocks/Stock Options:foldax:Active (exists now) ; Individual Stocks/Stock Options:BCI:Active (exists now) ; Individual Stocks/Stock Options:valcare:Active (exists now) ; Individual Stocks/Stock Options:trisol:Active (exists now) ; Individual Stocks/Stock Options:durvena:Active (exists now) ; Individual Stocks/Stock Options:cardiomech:Active (exists now) ; Consultant:zimmer:Active (exists now) ; Consultant:atricure:Active (exists now) ; Consultant:medtronic:Active (exists now) ; Consultant:boston scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Adding Years to Life and Life to Years

Sunday, 11/09/2025 , 03:30PM - 04:45PM

Main Event

More abstracts on this topic:
Paradigm Shifts in Lifetime Management of Advanced Heart Failure

Lindenfeld Joann

Advances in Lifetime Management of Mitral and Tricuspid Valve Disease

Chikwe Joanna

More abstracts from these authors:
Novel Valve Repairs and Re-do TAVR (TAV-TAV)

George Isaac, Cavalcante Joao, Leon Martin, Bapat Vinayak

You have to be authorized to contact abstract author. Please, Login
Not Available